Extended Data Fig. 1: Analysis of direct competitive binding characteristics of CA1, CB6 and ACE2.
From: A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2
a, b, Competition between CA1 and CB6 (a) or either mAb and ACE2 (b) for binding to the SARS-CoV-2 RBD. Octet sensors immobilized with the SARS-CoV-2 RBD were first saturated with one mAb or the kinetic buffer, and then exposed to the other mAb or ACE2 protein. The experiments were independently performed twice and similar results were obtained. The binding profiles of one experiment are shown.
